Hamwenawe Group Ltd, info@hamwenawe.com, 0787052425 / 0788870836 / 0728870836

Amatangazo y'Ibigo bya Leta Amatangazo y'Ibigo Byigenga

FDA-.Warning on potential risk of heart problems in patients

Jan 15, 2021

The Authority warns on potential risk of heart problems in patients with heart disease treated with Clarithromycin.

Aho amakuru y’itangazo yaturutse : Rwanda Food and Drugs Authority(Twitter)

Related Post

Amatangazo y'Ibigo bya Leta

REB-Announcement for Teacher Interchange (Permutation)

Sep 10, 2023
Amatangazo y'Ibigo bya Leta

Muhanga-Invitation for expressions of interest to construct a modern hotel

Jul 18, 2023
Amatangazo y'Ibigo bya Leta

UR-Announcement for online registration for academic year 2023

Jun 1, 2023

Amatangazo y'umwihariko

Amatangazo y'Abantu

Itangazo rya SIBORUREMA ryo guhindura amazina

April 4, 2024 Hamwenawe Group
Amatangazo y'Abantu

Itangazo rya HATANGIMBABAZI ryo guhindura amazina

April 2, 2024 Hamwenawe Group
Amatangazo y'Abantu

Itangazo rya MUKATETERO ryo guhindura amazina

September 11, 2023 Hamwenawe Group
Amatangazo y'Ibigo bya Leta

REB-Announcement for Teacher Interchange (Permutation)

September 10, 2023 Hamwenawe Group